CDYL2 p.Ser142Arg
c.424A>C · VCV3831100
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8722 | likely pathogenic |
|---|---|---|
| REVEL | 0.108 | moderately benign-leaning |
| SaProt | LLR -7.72 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 1.12 | unconstrained · MANE · 183 kb · p 0.014 · regional, not allelic |
| Overall | ||
| CADD | 23.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00212% | 47,201 |
| Admixed American | 0.00167% | 59,996 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,482 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CDYL2
- Protein
- p.Ser142Arg
- Coding
- c.424A>C
- MANE Select
- NM_152342
- Type
- single nucleotide variant
- Location
- chr16:80684730 (GRCh38)
- Gene constraint
- LOEUF 0.713 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 72.08 · 8 PDB
- Residue 142
- the 'disordered' region
Similar variants
- CDYL2 p.Gly355= Benign ★★ same type
- CDYL2 p.Thr261= Benign ★★ same type
- CDYL2 p.Ala114Gly Uncertain significance ★ ⚠ same type
- CDYL2 p.Ala114Thr Uncertain significance ★ ⚠ same type
- CDYL2 p.Ala286Val Uncertain significance ★ ⚠ same type
- CDYL2 p.Ala334Thr Uncertain significance ★ ⚠ same type
- CDYL2 p.Ala341Gly Uncertain significance ★ ⚠ same type
- CDYL2 p.Ala362Thr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdyl2-p-ser142arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown